Bilateral symmetrical adrenal hypermetabolism on FDG PET/CT due to Cushing syndrome in well differentiated neuroendocrine carcinoma
dc.authorid | Aktas, Gul Ege/0000-0003-4880-2275 | |
dc.authorid | Soyluoglu, Selin/0000-0003-4473-7138 | |
dc.authorwosid | Aktas, Gul Ege/R-1776-2019 | |
dc.contributor.author | Aktas, G. E. | |
dc.contributor.author | Demir, S. Soyluoglu | |
dc.contributor.author | Sarikaya, A. | |
dc.date.accessioned | 2024-06-12T11:01:45Z | |
dc.date.available | 2024-06-12T11:01:45Z | |
dc.date.issued | 2016 | |
dc.department | Trakya Üniversitesi | en_US |
dc.description.abstract | The F-18-FDG PET/CT scan has been suggested for whole-body imaging to identify ectopic adrenocorticotrophic hormone secreting tumours, but there are some challenges involved. The case of a patient is presented, who was admitted with the pre-diagnosis of ectopic ACTH syndrome. On the CT, a nodular lesion was detected in the medial segment of the right lung. The FDG uptake of the lesion seemed to be increased visually, but was not pathological quantitatively (SUVmax: 1.8) on the PET/CT. There was also diffuse increased uptake (SUVmax: 14.2) in the enlarged adrenal glands. The lesion was reported as a possible malignant lesion with low FDG affinity, such as a low grade neuroendocrine tumour, while the diffuse enlarged adrenal glands with high uptake were interpreted as diffusely hyperplasic, due to Cushing's syndrome. The patient was treated with a surgical wedge resection. The histopathological diagnosis confirmed that the tumour was a grade 1 well-differentiated neuroendocrine carcinoma. (C) 2015 Elsevier Espana, S.L.U. and SEMNIM. All rights reserved. | en_US |
dc.identifier.doi | 10.1016/j.remn.2015.08.011 | |
dc.identifier.endpage | 120 | en_US |
dc.identifier.issn | 2253-654X | |
dc.identifier.issue | 2 | en_US |
dc.identifier.pmid | 26522002 | en_US |
dc.identifier.scopus | 2-s2.0-84958178398 | en_US |
dc.identifier.scopusquality | Q3 | en_US |
dc.identifier.startpage | 118 | en_US |
dc.identifier.uri | https://doi.org/10.1016/j.remn.2015.08.011 | |
dc.identifier.uri | https://hdl.handle.net/20.500.14551/20996 | |
dc.identifier.volume | 35 | en_US |
dc.identifier.wos | WOS:000371940100009 | en_US |
dc.identifier.wosquality | Q4 | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.indekslendigikaynak | Scopus | en_US |
dc.indekslendigikaynak | PubMed | en_US |
dc.language.iso | en | en_US |
dc.publisher | Elsevier Espana Slu | en_US |
dc.relation.ispartof | Revista Espanola De Medicina Nuclear E Imagen Molecular | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | F-18-FDG PET/CT | en_US |
dc.subject | Neuroendocrine Carcinoma | en_US |
dc.subject | Bilateral Adrenal Hyperplasia | en_US |
dc.subject | Cushing's Syndrome | en_US |
dc.subject | Adrenal Metastasis | en_US |
dc.subject | PET | en_US |
dc.subject | Positron-Emission-Tomography | en_US |
dc.subject | Localization | en_US |
dc.subject | Diagnosis | en_US |
dc.title | Bilateral symmetrical adrenal hypermetabolism on FDG PET/CT due to Cushing syndrome in well differentiated neuroendocrine carcinoma | en_US |
dc.type | Article | en_US |